Alnylam Pharmaceuticals shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $5.5M | 20k | 274.98 |
| 2024-06-30 | $7.5M | 31k | 242.97 |
| 2024-03-31 | $536k | 3.6k | 148.62 |
| 2023-12-31 | $3.7M | 20k | 191.37 |
| 2023-09-30 | $2.8M | 16k | 177.03 |
| 2023-06-30 | $174k | 939 | 184.93 |
| 2023-03-31 | $118k | 589 | 200.00 |
| 2022-12-31 | $116k | 490 | 236.56 |
| 2022-09-30 | $12M | 60k | 200.15 |
| 2022-06-30 | $77k | 730 | 105.26 |
| 2022-03-31 | $174k | 1.1k | 163.16 |
| 2021-12-31 | $122k | 723 | 168.10 |
| 2021-09-30 | $332k | 1.8k | 188.51 |
| 2021-06-30 | $328k | 1.9k | 168.58 |
| 2021-03-31 | $148k | 1.1k | 140.28 |
| 2020-12-31 | $80k | 616 | 129.87 |
| 2020-09-30 | $87k | 598 | 145.48 |
| 2020-06-30 | $481k | 3.3k | 147.81 |
| 2020-03-31 | $129k | 1.2k | 108.77 |
| 2019-12-31 | $30k | 261 | 114.94 |
| 2019-09-30 | $15k | 192 | 78.12 |
| 2018-06-30 | $613k | 6.2k | 98.43 |
| 2018-03-31 | $741k | 6.2k | 118.98 |
| 2017-12-31 | $726k | 5.8k | 126.02 |